Nishiyama, Masahiro
Kyono, Yuki
Yamaguchi, Hiroshi
Kawamura, Aoi
Oikawa, Shizuka
Tokumoto, Shoichi
Tomioka, Kazumi
Nozu, Kandai
Nagase, Hiroaki
Article History
Received: 23 January 2023
Accepted: 24 November 2023
First Online: 27 November 2023
Competing interests
: The authors declare no competing interests relevant to this study. Outside the submitted work, KN is a member of advisory groups for Kyowa Kirin Co. Ltd., Toa Eiyo Ltd., and Taisho Pharmaceutical Co. Ltd. KN receives speakers bureaus from Sumitomo Pharma Co., Ltd., Chugai Pharmaceutical Co. Ltd., and Kyowa Kirin Co., Ltd. The sponsors had no role in the study design, collection, analysis or interpretation of the data, writing of the report, or in the decision to submit the manuscript for publication.